Chapter 3

Ultrasound in the Non-Invasive Evaluation of Fibrosis and Portal Hypertension

Annalisa Berzigotti MD

Annalisa Berzigotti MD

Researcher Specialist

Hepatic Haemodynamic Laboratory, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain

Ultrasound Section, Centre Diagnostic per la Imatge, Hospital Clinic, Barcelona, Spain

Search for more papers by this author
Marco Zoli MD, Professor of Medicine

Marco Zoli MD, Professor of Medicine

Department of Internal Medicine, Ageing and Nephrology, University of Bologna, Italy

Search for more papers by this author
Concepción Bru Saumell MD

Concepción Bru Saumell MD

Professor of Radiology Senior Consultant

University of Barcelona, Ultrasound Section, Centre Diagnostic per la Imatge, Hospital Clinic, Barcelona, Spain

Search for more papers by this author
Rosa Gilabert Sole MD

Rosa Gilabert Sole MD

Chief

Centre Diagnostic per la Imatge, Hospital Clinic, Barcelona, Spain

Search for more papers by this author
First published: 17 November 2010
Citations: 3

Summary

This chapter contains sections titled:

  • Introduction

  • Diagnosis and staging of fibrosis

  • Diagnosis of cirrhosis

  • Classification, diagnosis and quantification of portal hypertension

  • Prediction of prognosis in cirrhosis

  • New US technologies and future applications

  • References